IP Verse

Topical Localized Isoxazoline Formulation - EP2658542

The patent EP2658542 was granted to Intervet on Jun 4, 2025. The application was originally filed on Dec 22, 2011 under application number EP11813330A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2658542

INTERVET
Application Number
EP11813330A
Filing Date
Dec 22, 2011
Status
Patent Maintained As Amended
May 2, 2025
Grant Date
Jun 4, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

VIRBACOct 25, 2022GEVERS & ORESADMISSIBLE

Patent Citations (34) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2007066617
DESCRIPTIONUS3950360
DESCRIPTIONUS3984564
DESCRIPTIONUS4916154
DESCRIPTIONUS5288710
DESCRIPTIONUS5399717
DESCRIPTIONWO2007079162
DESCRIPTIONWO2009002809
DESCRIPTIONWO2009003075
DESCRIPTIONWO2009024541
DESCRIPTIONWO2010070068
DESCRIPTIONWO2010079077
DESCRIPTIONWO2011075591
DESCRIPTIONWO2011124998
INTERNATIONAL-SEARCH-REPORTUS2004116419
INTERNATIONAL-SEARCH-REPORTWO2006042099
INTERNATIONAL-SEARCH-REPORTWO2009024541
OPPOSITIONEP2658541
OPPOSITIONUS2007066617
OPPOSITIONUS5874479
OPPOSITIONWO2006042099
OPPOSITIONWO2006127399
OPPOSITIONWO2006127406
OPPOSITIONWO2006127487
OPPOSITIONWO2007079162
OPPOSITIONWO2008098168
OPPOSITIONWO2008151214
OPPOSITIONWO2009002809
OPPOSITIONWO2009003075
OPPOSITIONWO2009024541
OPPOSITIONWO2010070068
OPPOSITIONWO2010079077
OPPOSITIONWO2010096623
OPPOSITIONWO2018039508

Non-Patent Literature (NPL) Citations (6) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- "International Nonproprietary Names for Pharmaceutical Substances (INN", WORLD HEALTH ORGANIZATION (WHO) DRUG INFORMATION, (2003), vol. 17, no. 4, pages 278 - 279
INTERNATIONAL-SEARCH-REPORT- KUMAR S ET AL, "Comparative activity of three repellents against the ticks Rhipicephalus sanguineus and Argas persicus.", MEDICAL AND VETERINARY ENTOMOLOGY JAN 1992 LNKD- PUBMED:1600227, (199201), vol. 6, no. 1, ISSN 0269-283X, pages 47 - 50, XP002636872 [Y] 1-15 * the whole document *
OPPOSITION- Hussain A S, Et Al, "Influence of dimethylacetamide, N-N-diethyl-m-toluamide and i-dodecylazacycloheptan-2-one on ex vivo permeation of phosphonoformic acid through ratskin. Abstract", Methods Find Exp Clin Pharmacol, (19881101), pages 1 - 2, Methods Find Exp Clin Pharmacol, (20221104), XP055977835
OPPOSITION- Rufener Lucien, Et Al, "The novel isoxazoline ectoparasiticidelotilaner (Credelioâ„¢): a non-competitive antagonist specific to invertebrates y-aminobutyric acid-gated chloride channels (GABACIs)", Parasites & Vectors, (20170101), vol. 10, no. 530, pages 1 - 15, XP055977350
OPPOSITION- Xu Ming, Et Al, "13 The Discovery of Afoxolaner: A New Ectoparasiticide for Dogs", Ectoparasites - Drug discovery against moving targets, Wiley VCH, (20180101), pages 259 - 271, ISBN 978-3-527-34168-9, XP055977348
OPPOSITION- Ozoe, Y.et al, "The antiparasitic isoxazoline A1443 is a potent blocker of insect ligand-gated chloride channels", Biochemical and Biophysical Research Communications, Amsterdam NL , (20100101), vol. 391, no. 1, doi:10.1016/j.bbrc.2009.11.131, ISSN 0006-291X, pages 744 - 749, XP026823770

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents